Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in patients undergoing CIED procedure
NCT02450682Phase 2Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Feb 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in Atrial fibrillation (AFib), sponsored by Mayo Clinic. Planned start Feb 2016; status: withdrawn.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02450682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450682.